Engineering the type III secretion system in non-replicating bacterial minicells for antigen delivery

Nature Communications

Volumn 4, Issue , 2013, Pages

  Carleton, Heather A ^a   Lara Tejero, María ^a   Liu, Xiaoyun ^a   Galán, Jorge E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; NANOPARTICLE;

ANTIGEN; BACTERIUM; CYTOLOGY; NANOTECHNOLOGY; PROTEIN; SECRETION; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL CELL; BACTERIAL MINICELL; BIOENGINEERING; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOSTIMULATION; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; SALMONELLA TYPHIMURIUM; TYPE III SECRETION SYSTEM;

ANIMALS; ANTIGENS; BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; CD8-POSITIVE T-LYMPHOCYTES; GENETIC ENGINEERING; MICE; MICE, INBRED C57BL; OVALBUMIN; SALMONELLA TYPHIMURIUM;

BACTERIA (MICROORGANISMS); SALMONELLA TYPHIMURIUM;

EID: 84875852406     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2594     Document Type: Article

References (42)

1. Russmann, H. et al. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281, 565-568 (1998). (Pubitemid 28357372)
2. Chen, L. M., Briones, G., Donis, R. O. & Galan, J. E. Optimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development. Infect. Immun. 74, 5826-5833 (2006). (Pubitemid 44484569)
3. Amanna, I. & Slifka, M. Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology 411, 206-215 (2011).
4. Curtiss, 3rd. R. et al. New technologies in using recombinant attenuated Salmonella vaccine vectors. Crit. Rev. Immunol 30, 255-270 (2010).
5. Hegazy, W. & Hensel, M. Salmonella enterica as a vaccine carrier. Future Microbiol. 7, 111-127 (2012).
6. Moreno, M., Kramer, M., Yim, L. & Chabalgoity, J. Salmonella as live trojan horse for vaccine development and cancer gene therapy. Curr. Gene Ther 10, 56-76 (2010).
7. Gao, X. M. et al. Recombinant Salmonella Typhimurium strains that invade nonphagocytic cells are resistant to recognition by antigen-specific cytotoxic T lymphocytes. Infect. Immun 60, 3780-3789 (1992).
8. Yang, D. M. et al. Oral Salmonella Typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J. Immunol 145, 2281-2285 (1990). (Pubitemid 20343397)
9. Galan, J. E. & Wolf-Watz, H. Protein delivery into eukaryotic cells by type III secretion machines. Nature 444, 567-573 (2006). (Pubitemid 44864429)
10. Arnold, R., Jehl, A. & Rattei, T. Targeting effectors: the molecular recognition of Type III secreted proteins. Microbes Infect 12, 346-358 (2010).
11. Michiels, T. & Cornelis, G. R. Secretion of hybrid proteins by the Yersinia Yop export system. J. Bacteriol. 173, 1677-1685 (1991).
12. Russmann, H. et al. Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins. J. Immunol. 167, 357-365 (2001). (Pubitemid 32567800)
13. Wieser, A., Magistro, G., Nörenberg, D., Hoffmann, C. & Schubert, S. First multi-epitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS). Int. J. Med. Microbiol. 302, 10-18 (2012).
14. Zhu, X. et al. Tumor antigen delivered by Salmonella III secretion protein fused with heat shock protein 70 induces protection and eradication against murine melanoma. Cancer. Sci. 101, 2621-2628 (2010).
15. Chamekh, M. Immunomodulation using genetically engineered bacteria for type III-mediated delivery of heterologous antigens and cytokines: Potential application in vaccine and therapeutical developments. Immunopharmacol. Immunotoxicol. 32, 1-4 (2010).
16. Tartz, S. et al. Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid. Vaccine 26, 5935-5943 (2008).
17. Sevil Domènech, V., Panthel, K., Winter, S. & Rüssmann, H. Heterologous prime-boost immunizations with different Salmonella serovars for enhanced antigen-specific CD8 T-cell induction. Vaccine 26, 1879-1886 (2008).
18. Konjufca, V., Wanda, S., Jenkins, M. & Curtiss, III R. A recombinant attenuated Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers protection against E. acervulina challenge. Infect. Immun. 74, 6785-6796 (2006). (Pubitemid 44913153)
19. Evans, D. T. et al. Mucosal PRIMIng of SIV-specific CTL responses in rhesus macaques by the salmonella type III secretion antigen delivery system. J. Virol 77, 2400-2409 (2003). (Pubitemid 36222763)
20. Kotton, C. N. et al. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 gag antigen via the salmonella type III secretion system. Vaccine 24, 6216-6224 (2006). (Pubitemid 44247245)
21. Nishikawa, H. et al. In vivo antigen delivery by Salmonella Typhimurium type III secretion system for therapeutic cancer vaccine. J. Clin. Inv 116, 1946-1954 (2006). (Pubitemid 44033318)
22. Galán, J. Energizing type III secretion machines: what is the fuel? Nat. Struct. Mol. Biol 15, 127-128 (2008). (Pubitemid 351207524)
23. Frazer, A. & Curtiss, 3rd R. Production, properties and utility of bacterial minicells. Curr. Top Microbiol. Immunol. 69, 1-84 (1975).
24. Giacalone, M. et al. Immune responses elicited by bacterial minicells capable of simultaneous DNA and protein antigen delivery. Vaccine 24, 6009-6017 (2006). (Pubitemid 44080359)
25. Palm, N. & Medzhitov, R. Pattern recognition receptors and control of adaptive immunity. Immunol. Rev. 227, 221-233 (2009).
26. de Boer, P., Crossley, R. & Rothfield, L. A division inhibitor and a topological specificity factor coded for by the minicell locus determine proper placement of the division septum in E. coli. Cell 56, 641-649 (1989).
27. Collazo, C. & Galán, J. E. The invasion-associated type III system of Salmonella Typhimurium directs the translocation of Sip proteins into the host cell. Mol. Microbiol 24, 747-756 (1997). (Pubitemid 27229720)
28. Bajaj, V., Hwang, C. & Lee, C. A. hilA is a novel ompR.toxR family member that activates the expression of Salmonella Typhimurium invasion genes. Mol. Microbiol 18, 715-727 (1995).
29. Kubori, T. et al. Supramolecular structure of the Salmonella Typhimurium type III protein secretion system. Science 280, 602-605 (1998). (Pubitemid 28227766)
30. Lara-Tejero, M. & Galan, J. E. The Salmonella Typhimurium SPI-1 type III secretion translocases mediate intimate attachment to non-phagocytic cells. Infect. Immun. 77, 2635-2642 (2009).
31. Galyov, E. E. et al. A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa. Mol. Microbiol. 25, 1903-1912 (1997).
32. Zierler, M. K. & Galan, J. E. Contact with cultured epithelial cells stimulates secretion of Salmonella Typhimurium invasion protein InvJ. Infect. Immun. 63, 4024-4028 (1995).
33. Dick, L. R. et al. Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides. J. Immunol. 152, 3884-3894 (1994). (Pubitemid 24111060)
34. Karttunen, J., Sanderson, S. & Shastri, N. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl Acad. Sci. USA 89, 6020-6024 (1992).
35. Tacken, P., de Vries, I., Torensma, R. & Figdor, C. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7, 790-802 (2007). (Pubitemid 47480309)
36. Hogquist, K. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27 (1994). (Pubitemid 24035278)
37. Harty, J. T. & Bevan, M. J. CD8 + T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J. Exp. Med 175, 1531-1538 (1992).
38. Harty, J. T. & Pamer, E. CD8 T Lymphocytes Specific for the Secreted p60 Antigen Protect Against listeria monocytogenes Infection. J. Immunol 154, 4642-4650 (1995).
39. Kaniga, K., Bossio, J. C. & Galán, J. E. The Salmonella Typhimurium invasion genes invF and invG encode homologues to the PulD and AraC family of proteins. Mol. Microbiol 13, 555-568 (1994).
40. Lara-Tejero, M., Kato, J., Wagner, S., Liu, X. & Galan, J. E. A sorting platform determines the order of protein secretion in bacterial type III systems. Science 331, 1188-1191 (2011).
41. Patel, J. C., Hueffer, K., Lam, T. T. & Galan, J. E. Diversification of a Salmonella virulence protein function by ubiquitin-dependent differential localization. Cell 137, 283-294 (2009).
42. Ripoll, A. et al. In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario? Antimicrob. Agents Chemother. 55, 4530-4536 (2011).